You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tumor thrombosis-associated portal hypertension

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Guangzhou (Cadonilimab, transjugular intrahepatic portosystemic shunt (TIPS))

Not yet recruiting
  • Hepatocellular Carcinoma
  • Cadonilimab
  • transjugular intrahepatic portosystemic shunt (TIPS)
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 30, 2023

Portal Hypertension, Portal Vein Thrombosis, Esophageal Varix Bleeding Trial in Chengdu (preemptive TIPS, standard second

Not yet recruiting
  • Portal Hypertension
  • +3 more
  • preemptive TIPS
  • standard second prophylaxis
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Nov 3, 2023

HCC With Portal Vein Tumor Thrombosis on Basis of Risk Scoring

Completed
  • Hepatocellular Carcinoma
  • +2 more
    • Daegu, DalSeo-gu, Korea, Republic of
      Keimyung university Dongsan Medical Center
    Aug 16, 2023

    Liver Cirrhosis, Portal Hypertension, Non-Cirrhotic Portal Hypertension Trial in Freiburg (Implantation of a transjugular

    Recruiting
    • Liver Cirrhosis
    • +5 more
    • Implantation of a transjugular intrahepatic portosystemic shunt (TIPS)
    • Freiburg, Germany
      University Medical Center Freiburg, Department of Medicine II
    Mar 22, 2023

    Hepatocellular Carcinoma Trial in Wuhan (Sintilimab, Lenvatinib, Transarterial Chemoembolization (TACE))

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Wuhan, Hubei, China
      Tongji Hospital, Tongji Medical College, Huazhong University of
    Oct 17, 2023

    Cirrhosis, Splenectomy, Venous Thrombosis Trial in Yangzhou (Apixaban 2.5 MG, Dipyridamole 25Mg Tab, subcutaneous Low Molecular

    Recruiting
    • Cirrhosis
    • +3 more
    • Apixaban 2.5 MG
    • +2 more
    • Yangzhou, Jiangsu, China
      Clinical Medical College, Yangzhou University
    Apr 30, 2022

    Hepatocellular Carcinoma Non-resectable, Portal Vein Tumor Thrombus, Immune Checkpoint Inhibitors Trial in Nanning (Cadonilimab,

    Recruiting
    • Hepatocellular Carcinoma Non-resectable
    • +2 more
    • Nanning, Guangxi, China
      First Affiliated Hospital of Guangxi Medical University
    Sep 13, 2023

    Portal Hypetension and Bariatric Surgery (BARIAPORTAL)

    Recruiting
    • Bariatric Surgery Candidate
    • +2 more
    • Bariatric surgery
    • Nice, France
      CHU de NICE
    Dec 8, 2022

    Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)

    Recruiting
    • Cirrhosis
    • +3 more
    • Yangzhou, Jiangsu, China
      Clinical Medical College of Yangzhou University
    Mar 19, 2022

    HepatoCellular Carcinoma, Portal Vein Thrombosis Trial in Beijing (HAIC, Sorafenib)

    Completed
    • HepatoCellular Carcinoma
    • Portal Vein Thrombosis
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Oct 8, 2021

    Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)

    Not yet recruiting
    • Renal Cancer
    • +3 more
    • Aurora, Colorado
      University of Colorado Cancer Center
    Jul 24, 2023

    Predict Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma

    Completed
    • Neutrophil Extracellular Trap Formation
    • Portal Vein Tumor Thrombosis
    • test NETs markers
    • Qingdao, Shandong, China
      the Affiliated Hospital of Qingdao University
    Sep 2, 2021

    Hepatocellular Carcinoma, Portal Vein Thrombosis Trial in Beijing (HAIC, Lenvatinib 1, Camrelizumab 1)

    Recruiting
    • Hepatocellular Carcinoma
    • Portal Vein Thrombosis
    • HAIC
    • +4 more
    • Beijing, Beijing, China
      Peking Univerisity Cancer Hospital
    Jan 10, 2022

    Liver Cirrhosis, Portal Hypertension, Anticoagulant-induced Bleeding Trial in Xi'an (Heparin and Rivaroxaban)

    Completed
    • Liver Cirrhosis
    • +3 more
    • Heparin and Rivaroxaban
    • Xi'an, Shaanxi, China
      the first hospital of xi'an jiaotong University
    Aug 25, 2021

    Portal Vein Thrombosis and Budd-Chiari Syndrome

    Recruiting
    • Hepatic Vein Thromboses
    • +9 more
    • Rotational thromboelastometry
    • +2 more
    • Chandigarh, Choose Any State/Province, India
      Postgraduate Institute of Medical Education and Research
    Nov 5, 2021

    Hepatocellular Carcinoma Non-resectable, Portal Vein Tumor Thrombosis, Stereotactic Body Radiotherapy Trial in Hangzhou

    Completed
    • Hepatocellular Carcinoma Non-resectable
    • +2 more
    • stereotactic body raiotherapy
    • Hangzhou, Zhejiang, China
      the second affiliated hospital of Zhejiang University
    Jul 11, 2021

    Liver Cancer, Liver Transplant; Complications, Hepatocellular Carcinoma Trial in Shanghai (radiation, combination product, drug)

    Not yet recruiting
    • Liver Cancer
    • +4 more
    • intensity-modulated radiotherapy
    • +5 more
    • Shanghai, China
      Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
    Apr 20, 2022

    Endoscopic Resection of Early Esophageal Tumors in Context of

    Completed
    • Esophageal Neoplasms
    • +2 more
    • Endosocpic resection of early esophageal tumor
    • (no location specified)
    Jul 29, 2021

    Hepatocellular Carcinoma With Major Portal Vein Thrombosis Trial (HAIC (Hepatic arterial infusion chemo), HLX10 (PD-1 antibody),

    Not yet recruiting
    • Hepatocellular Carcinoma With Major Portal Vein Thrombosis
    • HAIC (Hepatic arterial infusion chemotherapy)
    • +3 more
    • (no location specified)
    Jun 24, 2021

    Portal Hypertension in Cirrhosis (Pan-CHESS1802)

    Recruiting
    • Hypertension, Portal
    • HVPG measurement
    • Beijing, China
    • +5 more
    Aug 16, 2021

    Pancreatic Adenocarcinoma Trial (Observationnal cohort)

    Not yet recruiting
    • Pancreatic Adenocarcinoma
    • Observationnal cohort
    • (no location specified)
    Mar 22, 2021

    Hepatocellular Carcinoma, Portal Vein Occlusion, Tumor Thrombus Trial in Guangzhou (TACE combined with iodine-125 seeds

    Active, not recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • TACE combined with iodine-125 seeds implantation
    • TACE
    • Guangzhou, Guangdong, China
      The 2nd Affiliated Hospital of Guangzhou Medical University
    Mar 2, 2022

    Carcinoma, Hepatocellular, Liver Tumors, Tumors, Glandular and Epithelial Trial in Nanning (Hepatic Resection, Radiofrequency

    Recruiting
    • Carcinoma, Hepatocellular
    • +2 more
    • Hepatic Resection
    • Radiofrequency Ablation
    • Nanning, Guangxi, China
      Department of Hepatobilliary Surgery, Affiliated Tumor of Guangx
    Jan 14, 2022

    Hepatocellular Carcinoma Trial in Guangzhou (Hepatic artery infusion chemo(HAIC), Durvalumab)

    Recruiting
    • Hepatocellular Carcinoma
    • Hepatic artery infusion chemotherapy（HAIC）
    • Durvalumab
    • Guangzhou, Guangdong, China
      Department of Minimally Invasive and Interventional Radiology, L
    May 18, 2022

    Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Trial in Shanghai (Tislelizumab, IMRT)

    Not yet recruiting
    • Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
    • Shanghai, China
      Zhongshan hospital, Fudan University
    Apr 19, 2021